Linda Avey, co-founder of 23andMe, has expressed her disappointment over the company’s recent Chapter 11 bankruptcy filing. Citing sources like CNBC, Avey shared her frustrations on social media, criticizing the leadership and direction taken post-Anne Wojcicki's takeover. She believes the downfall was due to a lack of governance and innovation focused on consumers, which hindered advancements in personalized health. As part of its restructuring, the company plans to seek qualified bids over the next 45 days, subject to approval.